期刊文献+

治疗冠心病、心绞痛的4种中成药限定日剂量数分析 被引量:2

Analysis of defined daily doses about four Chinese patent medicines for coronary heart disease and heart angina
下载PDF
导出
摘要 目的:通过比较长江流域6城市近3a治疗冠心病、心绞痛的中成药用药特点及趋势,为医院合理用药及医保用药提供参考。方法:依据上海、南京、杭州、武汉、成都、重庆6城市样本医院用药数据库中4种药物的用药数量、金额,根据各自的限定日剂量(DDD)值分别计算出各药的DDDs及每DDD价格,同种药物不同规格的DDDs分别计算,然后合并成该药的总的DDDs。结果:地奥心血康的每DDD价格最具优势,而复方丹参滴丸的用药成本最高;上海、杭州、南京的用药成本低于武汉、成都及重庆;大剂量包装的药物的每DDD价格相对更低。结论:DDDs可为中成药合理用药及医保用药提供参考。 AIM: To compare the characteristic and tendency of four kinds of Chinese patent medicines treating coronary heart disease and heart angina among six city of Yangtze River valleys for the last three years, and give reference to hospital and health insurance. METHODS: Defined daily doses (DDDs) and every DDD price based on defined daily dose were calculated respectively according to the quantity and price of four drugs retrieved from the pharmacy database of selected hospitals in Shanghai, Nanjing, Hangzhou, Wuhan, Chengdu, and Chongqing. The DDDs of same drug with different standard were calculated separately, and then the total DDDs were calculated. RESULTS: The every DDD's price of Di-ao Xinxuekang Jiaonang was the most preponderant; the medicine cost of Fufang Danshen Diwan was the highest; the medicine cost in Shanghai, Hangzhou, and Nanjing were lower than in Wuhan, Chengdu, and Chongqing; the every DDD's price of large dose package was relatively cheaper. CONCLUSION: DDDs could give reference to hospital and health insurance alout Chinese patent medicines.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2006年第8期637-639,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 经济学 药学 冠状动脉疾病 植物制剂 economics, pharmacy coronary disease plant preparations
  • 相关文献

参考文献2

二级参考文献7

  • 1王阶,荆鲁,衷敬柏,王永炎,马丽红,刘剑刚.血府逐瘀汤拆方临床研究[J].中国中药杂志,2004,29(8):803-807. 被引量:34
  • 2林凯旋,安辉,缪灿铭.通痹汤对冠心病心绞痛血液流变学及血脂的影响[J].医学理论与实践,2004,17(9):1001-1003. 被引量:3
  • 3ATC INDEX with DDDs 2000. WHO Collaborating Center for Drug Statistics Methodology : 2000. 1.
  • 4Cuidelines for ATC Classification and DDD Assignment. WHO Collaborating Center for Drug Statistics Methodology,. 1998. 1, 20- 6.
  • 5European drug utilization research group. Euro drug bulletin No. 1 April 1997.European Journal of Clinical Pharmacology. 52 - 3. May 1997.
  • 6Action programme on essential drug. 3 May 1999U RL: wwww. who, org/dap/edmconf, htm
  • 7Anthony J. Smith. Australian consensus conference on the management of hypertension. 1 Apr. 1999.

共引文献75

同被引文献6

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部